Bio-Rad Laboratories Geenius™ System and Sickle Cell kits

The Florida Department of Health is seeking to purchase a FDA-approved confirmatory assay system to perform HIV-1/HIV-2 Supplemental differentiation assay testing. The system must be able to test whole blood, serum, plasma, and in-house validated oral fluid to conform to the CDC 2014 HIV Diagnostic Algorithm guidelines. The Bio-Rad Laboratories Geenius™ System assays and controls are the only FDA-approved HIV-1/HIV-2 differential assay currently on the U.S. market and have been validated in-house for the confirmation of HIV-1 Oral Fluid meeting the guidelines required. Key points to consider: • The system must be FDA-approved and able to test various sample types. • The Bio-Rad Laboratories Geenius™ System is the only FDA-approved HIV-1/HIV-2 differential assay currently available. • The system has been validated in-house for the confirmation of HIV-1 Oral Fluid. • The estimated dollar amount for the purchase is $460,000.00.